| Tag | Content |
|---|
EnhancerAtlas ID | HS055-02281 |
Organism | Homo sapiens |
Tissue/cell | FT33 |
Coordinate | chr13:46928530-46930560 |
Target genes | |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| JUN(var.2) | MA0489.1 | chr13:46929131-46929145 | GGAAAATGACTCAT | + | 6.76 | | MEF2C | MA0497.1 | chr13:46929227-46929242 | TGCTATTTTTATCTC | - | 6.5 | | MYCN | MA0104.4 | chr13:46930315-46930327 | GGCCACGTGGCT | + | 6.37 | | MYCN | MA0104.4 | chr13:46930315-46930327 | GGCCACGTGGCT | - | 6.37 | | RUNX1 | MA0002.2 | chr13:46930258-46930269 | AAACCACAAAC | - | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09573 | chr13:46925808-46930539 | CD14 | | SE_11021 | chr13:46926777-46931216 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr13 | 46928720 | 46929572 | | chr13 | 46929409 | 46929462 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH13I046354 | chr13 | 46928293 | 46930078 | | GH13I046356 | chr13 | 46930141 | 46930290 |
|
Enhancer Sequence | TTTTTGCAAC TCTTCTGTAA ATCTAAAATT ATCTCAAAGA CAAAAGTTAA AAAAAATGTA 60
TCCTAGAAGC TAGAGGAATT TAACAGGAAA AGCCCAAAAT TATTTCTATG CTGTCTACAA 120
TCTGGGCCCC GCCTACATCT GCAGCATGTT TTCTCCTCCT ATTCTTACTC TCTGGCCACA 180
CAGGGTTTCT TTTACTTGCC ACAGGCCCTT TGCACATGAC GAACACCCCT ACTTCTGTGG 240
GCAATCACTT TCCGATGAAA CCTCTTACTC CCAGCTTCTC AAGCTCAGAT GAAGTTCCCT 300
TGCTGTAAAT CCCACGGCAC TCTTGACTCT TTTGTTACGT ACATCACTTT GTGTTACATA 360
CACTTACTTG GCTGATGAGT GTATCTTCCC TAAAAGATGA TAAGCAAGCT CCCTGAGGGC 420
AAGGCCACTG TACAAAAGTG CAGACACACA TCTCCATACC TGAACAAGCT TAGGGAAATA 480
ACAAAAAGTT GGTGGAGCGA TAGTCATATG TGTACAGTTT CTGACTCATG CATTCAATAT 540
TTACAGAAGC GCCAGGATAC AGTGGTTAAC CAAAGAGACA TGTTCCCCAC TAGATGTGCT 600
GGGAAAATGA CTCATTCAAA GAAAATCAGC AACAATGGTG ATGCCCGTCA GGCATTATCA 660
TCCAGTGTAG GAGAGGAAGC CCAGATCGAT TCCTGCTTGC TATTTTTATC TCTTGAAGTA 720
GGAGCTCCTC ATAGTCTTTT TCCTTCAAAA ACCGACTATC AAAGGCTAAG GGAACTCTTT 780
CCACAAAGCT CCTCTTTCCA GCCTTTTGCA GGTCAGACAT ACAGGTACCA TCAGAGCAGA 840
ACAAGTGATT CCCAGTCTCA AGGGGGAAAC TTGCATTTCT GACTGAGGAA AGCCCGAGCT 900
TTTTTTTTTT TTTTTTTGAG ACGGAGTCTC ACTTTGTCAT GCAGGCTGGA GTACAATAGT 960
GTGATCTCGG CTCACTGCAA CCTCTGCCTC CTGGTTTCAA GGAATTTTCC TGTCTCAGCC 1020
TCCCGAGTAG CTGGGATTAC AGGAGCCTGC CACCCATGCC TGGCTAATTT TTTTGTATTT 1080
TTAGTAGAGA TGTGGTTTCA CAATGTTGGC CAGGCTGGTC TCAAACTCCT GACCTCAGGT 1140
GATCCACCCA CCTTAGCCTC CCAAAGTGCT GGGATTACAG GTGGGAGACA CCGTGCCTGG 1200
CCCAGGAAAG CCTAATCTTC TAGGCCTCAG TTGGCCCAGG AATGATCCTC TCAGGCTACC 1260
TCCTCAAACT CTCAGAGAAG TTTGGCTAGC TCCTTGTTAA GCCATTCCTT TACTCAACAA 1320
ATATCTTTTG AAGACCTACT ATGTGCCAGG CACTCTTCTA GAAGCTGGAA ATAAAGTAAT 1380
AAATACAACA GACAACACAT GTGGCCTCAC AGAACTTATA ATCTAGTGTT GAAGACAGAT 1440
AATAATAAGA CATATTAGTA AAATATAAGA GACTATTTTA GAAAGACTGT GCTAAGAATA 1500
CAAAATAAGA AGGAACTTCT AAGAAAATAT TGTGCAAGAA AATAAAGAAA AAAAATAAGG 1560
ATGGGTAATA TAAAGCGTTC ATGGGATTGT CTGTGGCCAG CAGTGGGGCA AGACAGGTAT 1620
TTTAGATAGG GCAGCAAGGG AAGACCTCGT GACTTTGGAG TGAAAATGTG AAAGAAGCAA 1680
AGGAATTAGT CATGGGGGTG TCTGCAGAGA GAGCATTTGG GGGAGAGAAA ACCACAAACG 1740
CAAATATGTC AGAAGTGAGC CTGGCATTTT CAAGGGGCAG CAGGAGGCCA CGTGGCTGGA 1800
GCTGATGCCC AACAGGGAGA GAACTAGGAG GCTGGTCCTG GTGTCCTCGG TCCTAGTTGA 1860
TCACACAGCC TTGTCAGTCA TGATGGACTC CTCATGAAAA GGAGGGCAAC TTCTCTGAAG 1920
CTCTTATAAC AACTTCTCAT CAAAGGCATC TCTCACACAA GCAATGCGCT GCCCTACTTT 1980
GCTATTCTGG ACCTTGTCAT CACATCATAA GCAGGCGATC CATTATCCGT 2030
|
